Chronoscale Holdings Corp current report, 14 November 2023

SEC Filing Summary: Ekso Bionics Holdings, Inc. (8-K)

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Ekso Bionics Holdings, Inc. on November 14, 2023. The registrant is incorporated in Nevada and its common stock trades on the Nasdaq Capital Market under the symbol "EKSO". The report addresses a specific regulatory event regarding the company's listing status.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory compliance event and does not contain financial performance data.

Material Changes

The primary material change reported is the resolution of a listing deficiency. On September 29, 2023, the Company received notice from Nasdaq that it failed to meet the Minimum Bid Price Requirement of $1.00 per share for 30 consecutive business days. On November 14, 2023, the Company received written notice confirming it had regained compliance with this requirement, and the matter is now closed.

Guidance, Outlook, and Risks

The filing contains no management commentary, financial guidance, or outlook. The primary risk addressed was the potential delisting due to low stock price, which has been resolved as of the report date. No other contingencies or unusual items are disclosed in this document.

Investor Verification Checklist

  • Verify the current trading price of EKSO to ensure continued compliance with the $1.00 minimum bid price requirement.
  • Confirm the status of the Nasdaq listing on the exchange's official website.
  • Review subsequent filings for any new compliance notices or financial updates not included in this 8-K.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.